April 14, 2024 3:00 pm
£5m in funding support allocated to dental technology aimed at preventing tooth decay

In recent news, Edinburgh-based Calcivis has secured a £5 million funding round to support the expansion of its dental technology for early detection of tooth decay. The investment was led by the Scottish National Investment Bank, which provided £4 million, along with an additional £1 million from IFS Maven Equity Finance managed by Maven Capital Partners.

Founded in 2012 by CEO Adam Christie and CTO Bruce Vernon, Calcivis’ imaging system uses a biologic diagnostic to enable preventative treatment before tooth decay becomes irreversible. The company plans to first introduce its product in the US market after premarket approval from the FDA. Subsequent launches are planned in the UK and other European markets.

Adam Christie emphasized the importance of early diagnosis and treatment of tooth decay, highlighting the potential for Calcivis’ technology to revolutionize preventive oral healthcare. According to the World Health Organization, cavities impact over two billion people globally, underscoring the significance of innovative solutions like Calcivis.

Paul Callaghan, investment director at the Scottish National Investment Bank, praised Calcivis for its cutting-edge technology that enhances health and wellbeing. He expressed pride in supporting the company’s expansion into international markets, creating job opportunities in Scotland. The bank sees Calcivis’ technology as aligned with its innovation mission and anticipates significant health benefits for people in Scotland from the product’s launch in the UK.

Leave a Reply